Investors

Shareholder FAQ


On which stock exchange is Genprex’s shares traded and what is the ticker symbol?

Genprex’s common stock is listed on the Nasdaq Capital Market under the symbol “GNPX”. 

When did Genprex go public? What was the price?

The Company’s initial public offering of its common stock on the Nasdaq Capital Market occurred on March 29, 2018. The price was: $5 per share.

Where is Genprex’s corporate headquarters?

Genprex is headquartered in Austin, Texas.

When was Genprex founded?

Genprex was founded in April 2009.

Where is the company incorporated?

Genprex is incorporated under the laws of the State of Delaware.

Who makes up the Genprex Executive Management team and Board of Directors?

You can view our management team by visiting our website.

What is Genprex’s fiscal year?

Genprex’s fiscal year end is December 31.

What is the CUSIP number for Genprex’s shares?

For Genprex’s common shares listed on the Nasdaq Capital Market, the CUSIP number is 372446 104.

How can I purchase shares?

Shares can be purchased through a stockbroker of your choice.

Does Genprex pay dividends?

Currently, Genprex does not pay dividends.

Does Genprex have a direct stock purchase plan?

Currently, Genprex does not have a direct stock purchase plan.

Who is Genprex’s auditor?

Genprex’s auditor is Dazskal Bolton LLP.

Who is Genprex’s transfer agent and how do I contact them?

V Stock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
Ph: (212) 828-8436
Email: [email protected]

How can I replace my lost stock certificates?

Please contact our transfer agent, V Stock Transfer, LLC, through their website or by phone at (212) 828-8436.  The company can look up your records and make any necessary adjustments.  There is a fee involved for replacing lost certificates.

How do I report a change of mailing address?

You must send both your old and new addresses to our transfer agent, V Stock Transfer, LLC, by U.S. mail.  Each stockholder in question must sign the request for an address change.

Who is Genprex’s legal counsel?

Genprex’s legal counsel is Streusand, Landon & Ozburn LLP.

Where can I find out more about Genprex’s R&D programs?

You can view information on our platform and programs by visiting the Technology section of our website.

Where can I get the latest corporate news releases and financial reports?

You can view our recent press releases by visiting the Media section of our website.

How can I view documents Genprex has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?

Quarterly & Annual Reports and other investor materials are available under SEC Filings of the Investors & Media section of our corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.

How can I obtain further information or materials on Genprex?

More information can be found on the Genprex website and the SEC website.

Whom should I contact regarding investor inquiries?

GNPX Investor Relations
(877) 774-GNPX (4679) ext. #2
[email protected]

 
STAY IN THE KNOW WITH
EMAIL NEWS ALERTS
 
Don't miss out. Get our news delivered to your inbox.
 

 
close-link
 
Get Email News Alerts
 
close-link